These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7711103)

  • 1. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides.
    Soukchareun S; Tregear GW; Haralambidis J
    Bioconjug Chem; 1995; 6(1):43-53. PubMed ID: 7711103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
    Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
    Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Nalpha-Fmoc-cysteine(S-thiobutyl) derivatized oligodeoxynucleotides for the preparation of oligodeoxynucleotide-peptide hybrid molecules.
    Soukchareun S; Haralambidis J; Tregear G
    Bioconjug Chem; 1998; 9(4):466-75. PubMed ID: 9667948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N3- and 2-NH2-substituted 6,7-diphenylpterins and their use as intermediates for the preparation of oligonucleotide conjugates designed to target photooxidative damage on single-stranded DNA representing the bcr-abl chimeric gene.
    Crean CW; Camier R; Lawler M; Stevenson C; Davies RJ; Boyle PH; Kelly JM
    Org Biomol Chem; 2004 Dec; 2(24):3588-601. PubMed ID: 15592617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
    Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
    Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
    Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
    Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides.
    Hamma T; Miller PS
    Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach.
    Sumbatyan NV; Mandrugin VA; Deroussent A; Bertrand JR; Majer Z; Malvy C; Korshunova GA; Hollosi M; Gottikh MB
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1911-27. PubMed ID: 15628748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates.
    Boado RJ; Pardridge WM
    Bioconjug Chem; 1994; 5(5):406-10. PubMed ID: 7849069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel shift assay: demonstration of enhanced binding of oligo(delta)-L-ornithine-oligodeoxynucleotide conjugates to complementary DNA and RNA.
    Zhu T; Pooyan S; Wei Z; Leibowitz MJ; Stein S
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):69-74. PubMed ID: 8783798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides.
    Yang R; Yang J; Weliky DP
    Biochemistry; 2003 Apr; 42(12):3527-35. PubMed ID: 12653557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.
    Wild C; Dubay JW; Greenwell T; Baird T; Oas TG; McDanal C; Hunter E; Matthews T
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12676-80. PubMed ID: 7809100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties.
    Chaloin L; Vidal P; Lory P; Méry J; Lautredou N; Divita G; Heitz F
    Biochem Biophys Res Commun; 1998 Feb; 243(2):601-8. PubMed ID: 9480855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine preparation of thiol oligonucleotides: application to the synthesis of oligonucleotide-peptide hybrids.
    Ede NJ; Tregear GW; Haralambidis J
    Bioconjug Chem; 1994; 5(4):373-8. PubMed ID: 7948105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.
    Astriab-Fisher A; Sergueev DS; Fisher M; Shaw BR; Juliano RL
    Biochem Pharmacol; 2000 Jul; 60(1):83-90. PubMed ID: 10807948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antisense oligonucleotide-peptide conjugates with negative ionization electrospray mass spectrometry and liquid chromatography-mass spectrometry.
    Tengvall U; Auriola S; Antopolsky M; Azhayev A; Biegelman L
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):581-90. PubMed ID: 12899948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.